1. Home
  2. QLGN vs AGMH Comparison

QLGN vs AGMH Comparison

Compare QLGN & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • AGMH
  • Stock Information
  • Founded
  • QLGN 1996
  • AGMH 2015
  • Country
  • QLGN United States
  • AGMH Hong Kong
  • Employees
  • QLGN N/A
  • AGMH N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • AGMH EDP Services
  • Sector
  • QLGN Health Care
  • AGMH Technology
  • Exchange
  • QLGN Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • QLGN 3.1M
  • AGMH 3.5M
  • IPO Year
  • QLGN N/A
  • AGMH 2018
  • Fundamental
  • Price
  • QLGN $1.90
  • AGMH $2.21
  • Analyst Decision
  • QLGN
  • AGMH
  • Analyst Count
  • QLGN 0
  • AGMH 0
  • Target Price
  • QLGN N/A
  • AGMH N/A
  • AVG Volume (30 Days)
  • QLGN 125.5K
  • AGMH 96.5K
  • Earning Date
  • QLGN 08-26-2025
  • AGMH 08-26-2025
  • Dividend Yield
  • QLGN N/A
  • AGMH N/A
  • EPS Growth
  • QLGN N/A
  • AGMH N/A
  • EPS
  • QLGN N/A
  • AGMH 6.43
  • Revenue
  • QLGN N/A
  • AGMH $32,044,575.00
  • Revenue This Year
  • QLGN N/A
  • AGMH N/A
  • Revenue Next Year
  • QLGN N/A
  • AGMH N/A
  • P/E Ratio
  • QLGN N/A
  • AGMH $0.31
  • Revenue Growth
  • QLGN N/A
  • AGMH N/A
  • 52 Week Low
  • QLGN $1.61
  • AGMH $1.09
  • 52 Week High
  • QLGN $11.50
  • AGMH $109.50
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 32.76
  • AGMH 42.84
  • Support Level
  • QLGN $1.61
  • AGMH $2.02
  • Resistance Level
  • QLGN $1.91
  • AGMH $2.43
  • Average True Range (ATR)
  • QLGN 0.16
  • AGMH 0.20
  • MACD
  • QLGN -0.01
  • AGMH 0.02
  • Stochastic Oscillator
  • QLGN 26.48
  • AGMH 44.12

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: